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Abstract
Although human T cell surface glycoprotein CD4 Is the cellular receptor for human
Immunodeficiency virus 1 (HIV-1), the Introduction of the human CD4 gene into murine cells does
not render them susceptible to HIV-1 infection. Here we have established rabbit transfectant cell
lines expressing human CD4 on the cell surface and demonstrated that the CD4+ rabbit
transfectants could be readily Infected by HIV-1 by co-cultivating with a HIV-1-Infected human
MOLT-4 T cell line (MOLT-4/HIV). Avid syncytia formation was observed upon co-cultivation and
the syncytia abundantly produced HIV-1 mature particles, as revealed by electron microscopy. A
significant Increase of HIV-1 p24 antigen was also detected in the culture supernatant. The
syncytia formation was blocked by pretreating the transfectant with anti-human CD4 or by
pretreatlng the M0LT-4/HIV with antl-HIV-1 serum obtained from an infected individual, indicating
that the syncytia formed as a result of the Interaction of human CD4 on the rabbit transfectant
with the HIV-1 envelope protein expressed on M0LT-4/HIV. In contrast, only a very small
proportion of the rabbit transfectants expressed HIV-1-specific antigens upon Infection with an
HIV-1 stock. This may indicate that, although rabbit cells have partially acquired susceptibility to
HIV-1 by transfectlon of human CD4 gene, rabbit cells may further require such a molecule as
might be provided by MOLT-4 to become fully susceptible to HIV-1 Infection. The possibility of
the rabbit as a model for HIV-1 infection is also discussed.
Human immunodeficiency virus 1 (HIV-1) has been shown to be
the causative agent of acquired immunodeficiency syndrome
(AIDS) in man (1 -3). Although much information is accumulating
on the biology and molecular structure of HIV-1, very little is
known about the infection process and induction mechanisms
underlying AIDS. To develop successful vaccines and therapeutic
regimens for AIDS, an important requirement is a readily available
animal model.
Rabbit T cells have been reported to be infectable with a high-
titered HIV-1 stock in vitro (4) and in vivo (5,6). Therefore, we
considered it likely that cell surface expression of human CD4
renders rabbit T cells highly susceptible to HIV-1 infection and
that rabbits introduced with the human CD4 gene may serve as
an important preclinical animal model for AIDS. In this study, we
have generated rabbit T cell lines expressing human CD4 by
cDNA transfection and then investigated whether these rabbit
transfectants have acquired susceptibility to HIV-1 infection upon
expressing human CD4 on the cell surface.
First, we attempted to introduce human CD4 cDNA into rabbit
T cell lines that had been infected with human T cell leukemia
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Fig. 1. Row cytometnc analysis of human CD4 expression on rabbit
transfectants. Ceils were incubated with biotmyiated anti-numan CD4 rnAb,
anti-T4 (Olympus Optical Co. Ltd, Tokyo, Japan) for 30 mm at 4°C and
then washed with PBS containing 0 .1% BSA (Sigma, St Louis, MO).
Subsequently cells were incubated with avidin - FITC (Coulter, Hialeah,
FL) for 30 min at 4°C and washed Cells were analysed by a fluorescence-
activated cell sorter, EPICS-CS (Coulter).
virus type 1 (HTLV-1). To this end, we subcloned a full-length
cDNA encoding human CD4 (7) into the expression vector
BCMGSNeo (8), which contains the human cytomegalovirus
promoter/enhancer and the bovine papilloma virus (BPV) 69%
fragment (9) to construct BCMGSNeo-hCD4. The BCMGSNeo-
hCD4 was then introduced into the HTLV-1 -positive rabbit T cell
lines, F648b (10) and H446 (11), and G418-resistanttransfectant
clones were isolated. Each clone was examined for the
expression of human CD4 on the cell surface by the use of a
biotinylated anti-human CD4 monoclonal antibody. The isolated
transfectant clones, FC416-3 (F648b-derived) and HC427-1
(H446-derived), stably expressed human CD4 and their
expression levels were at least several times higher than that of
the human T cell line MOLT-4 as assessed by flow cytometry
(Fig. 1). In line with this, Scatchard plot analysis using <25|.
labeled Fab' fragments of anti-human CD4 monoclonal antibody,
which recognizes an HIV-1 binding epitope of human CD4,
revealed that HC427-1 and FC416-3 expressed 370,000 and
56,000 sites/cell of human CD4 respectively, whereas MOLT-4
expressed 13,000 sites/cell (not shown).
We then asked whether the expression of human CD4 on the
cell surface rendered these rabbit T cell lines susceptible to HIV-1
infection. First, we examined the ability of these transfectants to
support syncytia formation. It has been shown that syncytia form
upon co-cultivating human CD4+ cells with HIV-1-infected cells
and that this represents a critical cellular process leading to the
intracdlular replication and extracellular release of HIV-1 particles
(12-14). Whereas neither a parental cell line F648b nor a control
cell line F20 transfected with the same expression vector but
containing a control cDNA formed syncytia following co-
cultivation with MOLT-4 which had been infected with HIV-1
(MOLT-4/HIV) (15), human CD4+ transfectant FC416-3
vigorously formed syncytia with MOLT-4/HIV after 24 h of co-
culture (Fig. 2 a - c and Table 1). This heterocellular interaction
was completely abrogated by pretreating either FC416-3 cells
with anti-human CD4 monoclonal antibody (OKT4A) or
MOLT-4/HIV cells with polyclonal anti-HIV-1 serum from an
infected individual (not shown), indicating that the syncytia
formation was due to the interaction between human CD4
expressed on rabbit cells and HIV-1 envelope protein expressed
on MOLT-4/HIV.
When these syncytia were examined by electron microscopy,
extracellular virions with morphology typical of HIV-1 (16) were
found abundantly (Fig. 2d and e). Moreover, the notion that HIV-1
replication was actively occurring in the syncytia was further
substantiated by the increase of HIV-1 p24 antigen in the culture
supernatant (Table 1). The culture supernatant of FC416-3
co-cultured with MOLT-4/HIV contained a much higher level of
HIV-1 capsid protein p24 than either the culture supernatant
obtained from F648b or F20 co-cultured with MOLT-4/HIV, or
that of MOLT-4/HIV. Furthermore, preliminary experiments
indicated that the culture supernatant of FC416-3 forming syncytia
was able to transmit HIV-1 into the indicator cell line MOLT-4 (not
shown). These results together show that infectious wild-type
HIV-1 vinons actually replicated in the syncytia and were released
extracellularly. The same treatment of murine lymphoma EL-4
that had been transfected with human CD4 resulted in no syncytia
formation at all (not shown).
To further assess the susceptibility to HIV-1 infection of the rab-
bit transfectants expressing human CD4, we inoculated the
human CD4+ rabbit transfectants with cell-free HIV-1 virus
particles (HTLV-IIIB) at a multiplicity of infection of 0.5. The rabbit
transfectant clones (FC416-3 and HC427-1) as well as the
parental cell lines (F648b and H446) and a control rabbit cell
line (F20) were examined by an immunofluorescence assay for
the cell surface expression of HIV-1-specific antigens following
the HIV-1 inoculation (Table 2). Although all of the control cell
lines, including the parental and mock-transfected lines, remained
negative for expression of HIV-1 antigens throughout the course
of examination, small but significant proportions (0.5 -1.0%) of
the transfectants expressing human CD4 became strongly
positive for the HIV-1 antigens subsequent to the infection.
Comparable results were obtained by the use of anti-gp120 mAb
0.5/3 (not shown). While previous study by others has shown that
the rabbit T cell line, H446, is susceptibe to HIV-1 infection (4),
we detected no HIV-1 antigens on H446 cells after the inocula-
tion with HIV-1. The viral antigen expression was stable in
HC427-1 and easily detectable even at day 20 postinfection,
whereas in FC416-3 the antigen expression was transient and
became negative at day 9. Although HC427-1 expressed several
times more human CD4 than FC416-3 (not shown), it remains
to be determined whether this could account for the apparent
difference in the sensitivity to HIV-1 infection. It has been
demonstrated in man that surface expression levels of CD4 do
not necessarily correlate with sensitivity of these cells to HIV-1
infection (17,18). The apparent lack of susceptibility of H446 and
the relatively low percentages of infected cells in the transfectants
remain to be resolved, but it may possibly be due to a lower titer
of HIV-1 stock used for the cell-free infection in the present study.
Alternatively, rabbit T cells expressing human CD4 may further
require such a molecule as might be provided by MOLT-4 to
become readily infected with HIV-1. For instance, it has been
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Fig. 2. Human CD4-dependent syncytia formation of rabbrt transfectants with M0LT-4/HIV. 3 x 105 rabbit cells were incubated with 3 x 10s
M0LT-4/HIV cells in a well of 24-well plates at 37°C. After 24 h, cultures were photographed at x 100 magnification. When the rabbit parental cell
line F648b (a) or a rabbit transfectant expressing human IL-2 receptor a-chain (b) was co-cultured with MOLT-4/HIV, no syncytia formation was
found. In contrast, when human CD4+ rabbit transfectant FC416-3 was co-cultured with MOLT-4/HIV, prominent syncytia formation was observed
(c). Electron micrograph (X3400) (d) and (X43.000) (e) of the syncytium. Many extracellular mature virions with conical core characteristic of HIV-1
were visualized.
reported that frans-acting cellular factors critical for Rev function
are present in human but not in murine cells, which may be partly
responsible for the narrow HIV-1 tropism (19). Clearly further study
is required to resolve this issue.
Although generation of animal models for HIV-1 infection is
critical in devising therapeutic means for AIDS, attempts to
produce mouse models for HIV-1 infection have met with
difficulties. Transgenic mice expressing human CD4 do not
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Table 1. Induction of syncytia formation and supernatant p24
activity by cc-culturing a human CD4+ rabbit transfectant with
HIV-1-infected MOLT-4 (MOLT-4/HIV)















3 x 105 cells were incubated with 3 x 105 MOLT-4/HIV cells in a well
of 24-well plate at 37°C. After 24 h the number of syncytia per viewfield
was counted under an inverted phase contrast microscope.
Simultaneously the culture supernatants were harvested and filtered
through a 0.45 ^m filter and HIV-1 p24 antigen activity was measured
by using an HIV p24 antigen ELISA (Abbott Laboratories, North Chicago,
IL)
Table 2. Expression of HIV-1-specific antigens on human CD4^
rabbit transfectants after inoculation with HIV-1
administration of large numbers of HIV-1-infected human cells
into CD4 transgenic rabbits will produce any significant disease
symptoms and we are currently attempting to produce such
animals.
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Infection of cells with HIV-1 was made at a multiplicity of infection of
0.5 at 37°C for 1 h. After adsorption of HIV-1, the cells were washed
twice with RPM11640, resuspended in RPM11640 medium supplemented
with 10% fetal bovine serum (General Scientific Laboratories, Los Angeles,
CA) at a concentration of 4 x 105 cells/ml, and then incubated at 37°C.
The cells were taken from the cultures at indicated times, smeared on
microscope slides, air-dried, and fixed with methand. Fixed slides were
incubated with 1:1,000 diluted anti-HIV-1 serum from an AIDS patient
at 37°C for 30 mm and then washed with PBS. Subsequently the slides
were incubated with fluorescein isothiocyanate (FITC)-conjugated anti-
human IgG (Dakopatts A/S, Copenhagen, Denmark) at 37°C for 30 mm
and then washed with PBS. Cells were examined under a fluorescence
microscope. +, 0.5 - 1.0% of cells are HIV-1-specific antigen positive,
- , antigen negative.
appear to support the replication of HIV-1 (S. Aizawa and
M. Taniguchi, personal communication). Furthermore, mice
producing infectious HIV particles in their tissues as a result of
introduction of HIV provira) DNA into the germline develop no
AIDS disease symptoms (20). Severe combined immunodeficient
(SCID) mice grafted with human cells have been shown to
support the HIV-1 replication (21), but our preliminary results
indicate that production of such reconstituted mice involves
considerable technical difficulties. In contrast, previous studies
have shown that rabbit cells allow HIV-1 virus to replicate in vitro
(4) and in vivo (5,6), although not as efficiently as do human cells.
No AIDS-like immunodeficiency has been observed in the HIV-1
infected rabbits. In the present study, we demonstrated that rabbit
transfectant cell lines could be readily infected by HIV-1 by
co-cultivation with HIV-1 infected human cells. Although low
susceptibility of these transfectants to a HIV virus stock may well
be a limiting factor, it would still be interesting to examine whether
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